ArticleHealth science reports2022

Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection.

Akio Miyasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.